Literature DB >> 16919742

Trends in opioid-related fatal overdoses in Massachusetts, 1990-2003.

William Fernandez1, Holly Hackman, Loreta McKeown, Teresa Anderson, Beth Hume.   

Abstract

UNLABELLED: Since 1997, poisoning, particularly from heroin and other opioids, has been the leading cause of injury mortality in Massachusetts. Our aim was to describe recent trends in opioid-related poisoning deaths among Massachusetts residents.
METHODS: Massachusetts death files for the years 1990-2003, as coded by International Classification of Disease, Ninth Revision and International Classification of Disease, Tenth Revision, were used to identify all poisoning deaths and opioid-related poisoning deaths; rates were age-adjusted and grouped by year, sex, and race/ethnicity.
RESULTS: From 1990 to 2003, opioid-related fatal poisoning rates increased by 529% from 1.4 per 100,000 in 1990 to 8.8 per 100,000 in 2003. The proportion of total poisoning deaths associated with opioids rose from 28% in 1990 to 69% in 2003.
CONCLUSIONS: Massachusetts experienced a significant increase in opioid-related poisoning death rates. To guide future public health interventions, further investigation is necessary to better delineate the specific opioids involved, the circumstances surrounding these deaths, and the medical and behavioral health care options available.

Entities:  

Mesh:

Year:  2006        PMID: 16919742     DOI: 10.1016/j.jsat.2006.04.008

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  12 in total

1.  Development of a coroner-based surveillance system for drug-related deaths in Los Angeles county.

Authors:  Isabelle Sternfeld; Nicolle Perras; Patti L Culross
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

2.  Incidence of adverse cardiovascular events in adults following drug overdose.

Authors:  Alex F Manini; Lewis S Nelson; Barry Stimmel; David Vlahov; Robert S Hoffman
Journal:  Acad Emerg Med       Date:  2012-06-22       Impact factor: 3.451

3.  Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.

Authors:  Hannah L F Cooper; Joanne E Brady; Samuel R Friedman; Barbara Tempalski; Karla Gostnell; Peter L Flom
Journal:  J Urban Health       Date:  2008-08-16       Impact factor: 3.671

4.  Emergency department visits among recipients of chronic opioid therapy.

Authors:  Jennifer Brennan Braden; Joan Russo; Ming-Yu Fan; Mark J Edlund; Bradley C Martin; Andrea DeVries; Mark D Sullivan
Journal:  Arch Intern Med       Date:  2010-09-13

5.  Data Sources Regarding the Nonmedical Use of Pharmaceutical Opioids in the United States.

Authors:  Teresa Schmidt; Amanuel Zimam; Alexandra Nielsen; Wayne Wakeland
Journal:  Rev Health Care       Date:  2014

6.  Examining Fatal Opioid Overdoses in Marion County, Indiana.

Authors:  Bradley Ray; Kenna Quinet; Timothy Dickinson; Dennis P Watson; Alfarena Ballew
Journal:  J Urban Health       Date:  2017-04       Impact factor: 3.671

7.  Opioid prescriptions for chronic pain and overdose: a cohort study.

Authors:  Kate M Dunn; Kathleen W Saunders; Carolyn M Rutter; Caleb J Banta-Green; Joseph O Merrill; Mark D Sullivan; Constance M Weisner; Michael J Silverberg; Cynthia I Campbell; Bruce M Psaty; Michael Von Korff
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

8.  Impact of South American heroin on the US heroin market 1993-2004.

Authors:  Daniel Ciccarone; George J Unick; Allison Kraus
Journal:  Int J Drug Policy       Date:  2009-02-06

9.  Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.

Authors:  Maya Doe-Simkins; Alexander Y Walley; Andy Epstein; Peter Moyer
Journal:  Am J Public Health       Date:  2009-05       Impact factor: 9.308

10.  Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?

Authors:  Igor Kissin
Journal:  J Pain Res       Date:  2013-07-04       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.